Our Pricing

Complete Mounjaro Injection Guide for UK Bundles

Published on: June 03, 2026

This comprehensive mounjaro injection guide UK provides step-by-step instructions for safe and effective administration of your Mounjaro KwikPen. Whether you're starting treatment or need a refresher, our expert pharmacist guidance ensures you inject confidently and correctly every time.

Understanding Your Mounjaro KwikPen Before Injection

The Mounjaro KwikPen is a pre-filled, single-dose injection device containing tirzepatide, the first dual GIP/GLP-1 receptor agonist licensed by the MHRA for weight management in the UK [1]. Each pen delivers a precise dose through a simple push-button mechanism, eliminating the need for manual dose measurement.

Before your first injection, familiarise yourself with the pen components: the medicine window shows the clear, colourless solution, the dose button administers the injection, and the base cap protects the needle until use. Store unopened pens in the refrigerator between 2°C and 8°C, and never freeze them [2].

Your prescriber will determine your starting dose based on your medical assessment. Mounjaro follows a gradual dose escalation schedule, typically starting at 2.5mg weekly for four weeks, then increasing every four weeks to minimise gastrointestinal side effects whilst optimising weight loss results [1].

Checking Your Pen Before Use

Always inspect your Mounjaro pen before injection. The solution should be clear and colourless — if you notice cloudiness, particles, or discolouration, do not use that pen and contact our pharmacy team on (+44) 116 4646009. Check the expiry date printed on the pen label, and ensure the pen hasn't been frozen or exposed to temperatures above 30°C [2].

Step-by-Step Mounjaro Injection Instructions

Wash your hands thoroughly with soap and water before handling your Mounjaro pen. Remove one pen from the refrigerator and let it reach room temperature for 30 minutes — injecting cold medicine can cause discomfort at the injection site.

Choose your injection site: abdomen (at least 5cm away from your navel), front of thighs, or back of upper arms. Rotate injection sites each week to reduce the risk of lipodystrophy, a condition where repeated injections in the same area can cause lumps or skin changes [3]. Clean the chosen area with an alcohol wipe and allow it to dry completely.

Remove the base cap by pulling it straight off — you'll hear a click when the pen is ready. Place the pen perpendicular to your skin and press firmly until the pen body touches your skin. Press and hold the dose button until you hear a second click, then continue holding for an additional 10 seconds to ensure the full dose is delivered [2].

After 10 seconds, remove the pen from your skin. A small drop of medicine at the injection site is normal and doesn't affect your dose. Do not rub the injection site. Dispose of the used pen immediately in a sharps container — never reuse or share pens, even if the needle is changed.

Timing Your Weekly Mounjaro Injection

Mounjaro is administered once weekly on the same day each week, at any time of day, with or without food. If you miss a dose and it's within four days of your scheduled injection, administer it as soon as you remember. If more than four days have passed, skip the missed dose and resume your regular schedule — never double up doses [2].

Common Injection Technique Mistakes to Avoid

The most frequent error UK patients make is removing the pen too quickly after pressing the dose button. Tirzepatide has a higher viscosity than some other injectable weight loss medications, requiring the full 10-second hold time to ensure complete dose delivery [2]. Setting a mental countdown or watching the injection window until the yellow indicator disappears helps ensure proper administration.

Another common mistake is injecting through clothing or not allowing the alcohol swab to dry. Wet alcohol can sting during injection and may affect medicine absorption. Always inject directly onto clean, dry skin in a well-lit area where you can clearly see what you're doing.

Some patients report bruising or bleeding at injection sites, which typically results from hitting small blood vessels. Whilst this doesn't affect treatment efficacy, applying gentle pressure with a clean cotton wool ball for 30 seconds after injection can minimise bruising. If you're taking anticoagulants or have a bleeding disorder, discuss injection technique with your prescriber during your clinical assessment [3].

Managing Injection Site Reactions

Mild redness, swelling, or itching at the injection site affects approximately 2-4% of patients using tirzepatide and usually resolves within a few days [1]. Applying a cool compress can provide relief. If you develop severe pain, significant swelling, or signs of infection such as warmth and pus, contact our clinical team immediately.

Mounjaro Storage and Travel Guidance for UK Patients

Proper storage maintains Mounjaro's effectiveness throughout your treatment. Unopened pens must be refrigerated between 2°C and 8°C until the expiry date printed on the label. Once you've started using a pen (or removed it from refrigeration), it can be stored at room temperature below 30°C for up to 21 days [2].

When travelling within the UK or abroad, transport your Mounjaro pens in an insulated cool bag with ice packs, ensuring the pens don't come into direct contact with ice or frozen gel packs. Airport security allows injectable medications in carry-on luggage — carry your prescription or a letter from our pharmacy confirming your treatment if requested.

If you're travelling across time zones, maintain your weekly injection schedule based on UK time initially, then gradually shift your injection day by a few hours each week until you're aligned with your new time zone. This approach minimises disruption to your treatment routine whilst abroad.

What to Expect During Your Mounjaro Treatment Journey

Clinical trials show tirzepatide produces progressive weight loss over 72 weeks, with most patients noticing appetite reduction within the first two weeks of treatment [1]. The SURPASS-3 trial demonstrated an average body weight reduction of 22.5% at the highest maintenance dose, though individual results vary based on adherence, diet, and physical activity levels [1].

Gastrointestinal side effects such as nausea, diarrhoea, and reduced appetite are most common during the first 4-8 weeks and typically improve as your body adjusts to each dose level. The gradual dose escalation schedule is specifically designed to minimise these effects whilst optimising treatment outcomes [3].

Your UK prescriber will schedule follow-up assessments every 12 weeks to monitor your progress, adjust dosing if needed, and address any concerns. At Cured Pharmacy, our clinical team remains available throughout your treatment journey to answer questions about injection technique, side effect management, or any aspect of your care.

Comparing Injectable Weight Loss Treatments Available in the UK

Mounjaro represents the latest advancement in injectable weight loss medication, but several alternatives are available through UK pharmacies subject to prescriber approval. Wegovy contains semaglutide, a single GLP-1 receptor agonist that demonstrated 14.9% average weight loss over 68 weeks in the STEP-1 trial [4]. Saxenda uses liraglutide, an earlier-generation GLP-1 medication requiring daily rather than weekly injections.

The choice between these treatments depends on your medical history, weight loss goals, tolerance to side effects, and practical considerations like injection frequency. Tirzepatide's dual-receptor mechanism produces greater weight loss in head-to-head comparisons, but individual response varies [1][4].

All injectable weight loss medications require ongoing lifestyle modifications including reduced calorie intake and increased physical activity. Clinical trials demonstrating efficacy included comprehensive diet and exercise programmes, and real-world results depend significantly on maintaining these behavioural changes throughout treatment [1][4].

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
2. Eli Lilly and Company. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen: Summary of Product Characteristics. Electronic Medicines Compendium. https://www.medicines.org.uk/emc/product/14395 [accessed 13 August 2026]
3. Frid, A. H., Kreugel, G., Grassi, G., et al. (2016). New Injection Recommendations for Patients with Diabetes. Diabetes & Metabolism, 42(Suppl 1), S3–S23. https://doi.org/10.1016/S1262-3636(16)30006-6 [accessed 13 August 2026]
4. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Mounjaro is a prescription-only medicine and requires approval from a UK prescriber following online consultation.